Drug
Lad328
Lad328: highest development phase Phase 2, developed by Almirall. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Almirall
Trials
| Drug | Phase | Indication |
|---|---|---|
| LAD328 NCT07547813 | Phase 2 | Hidradenitis Suppurativa |
Latest
No recent events.
Follow Lad328 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.